Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 132, Issue 16, Pages 1837-1853
Publisher
Portland Press Ltd.
Online
2018-08-01
DOI
10.1042/cs20180312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular smooth muscle contraction in hypertension
- (2018) Rhian M Touyz et al. CARDIOVASCULAR RESEARCH
- Rho Kinases and Cardiac Remodeling
- (2016) Toru Shimizu et al. CIRCULATION JOURNAL
- RhoA/Rho-Kinase in the Cardiovascular System
- (2016) Hiroaki Shimokawa et al. CIRCULATION RESEARCH
- Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels
- (2016) Camila Fierro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Increased rho kinase activity in mononuclear cells of dialysis and stage 3–4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications
- (2016) Lorenzo A. Calò et al. LIFE SCIENCES
- Angiotensin II Activates the RhoA Exchange Factor Arhgef1 in HumansNovelty and Significance
- (2015) Maria Luigia Carbone et al. HYPERTENSION
- The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling
- (2015) Verdiana Ravarotto et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease
- (2015) Svenja Hartmann et al. Frontiers in Pharmacology
- Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
- (2014) Maria Paz Ocaranza et al. JOURNAL OF HYPERTENSION
- Increased Rho-Kinase Activity in Hypertensive Patients With Left Ventricular Hypertrophy
- (2013) L. Gabrielli et al. AMERICAN JOURNAL OF HYPERTENSION
- Rho-Kinase in Leukocytes
- (2013) Hiroyuki Watanabe et al. CIRCULATION JOURNAL
- Rho-Kinase Activation in Patients With Heart Failure
- (2013) Zhulanqiqige Do.e et al. CIRCULATION JOURNAL
- Potential Benefits of Rho-kinase Inhibition in Arterial Hypertension
- (2013) Olaf Grisk CURRENT HYPERTENSION REPORTS
- Rho-Associated Kinase Activity Is a Predictor of Cardiovascular Outcomes
- (2013) Masato Kajikawa et al. HYPERTENSION
- Rho Kinases in Cardiovascular Physiology and Pathophysiology
- (2013) Jianjian Shi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans
- (2013) Caroline J. Smith et al. MICROVASCULAR RESEARCH
- Increased Rho kinase activity in congestive heart failure
- (2012) Ming Dong et al. EUROPEAN JOURNAL OF HEART FAILURE
- Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure
- (2011) María Paz Ocaranza et al. AMERICAN HEART JOURNAL
- Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors
- (2011) Junko Soga et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension
- (2011) N Fujimura et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension
- (2011) María P Ocaranza et al. JOURNAL OF HYPERTENSION
- Calcium channel blocker and Rho-associated kinase activity in patients with hypertension
- (2010) Takaki Hata et al. JOURNAL OF HYPERTENSION
- Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor
- (2009) Matthias Löhn et al. HYPERTENSION
- Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases
- (2008) Clark A. Sehon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase
- (2007) R Kast et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started